Search Prime Grants

UG3DA065155

Cooperative Agreement

Overview

Grant Description
DEEPENING OPTICAL IMAGING WITH NEXT-GENERATION PHOTOACOUSTIC COMPUTED TOMOGRAPHY - ABSTRACT DEEP-TISSUE IMAGING REMAINS A FUNDAMENTAL CHALLENGE IN BIOMEDICAL OPTICS DUE TO LIGHT SCATTERING, LIMITING HIGH- RESOLUTION OPTICAL IMAGING TO DEPTHS OF APPROXIMATELY 1 MM, ALSO REFERRED TO AS THE OPTICAL DIFFUSION LIMIT DUE TO THE USE OF BALLISTIC OR QUASI-BALLISTIC PHOTONS. PHOTOACOUSTIC TOMOGRAPHY (PAT) UNIQUELY CIRCUMVENTS THIS LIMITATION BY USING DEEP PENETRATING DIFFUSE LIGHT TO EXCITE PHOTOACOUSTIC WAVES, WHICH ARE THEN DETECTED ULTRASONICALLY, LEVERAGING THE LOW SCATTERING OF SOUND IN BIOLOGICAL TISSUES TO PROVIDE HIGH SPATIAL RESOLUTION. THIS PROPOSAL AIMS TO PUSH THE IMAGING DEPTH OF PAT FROM THE CURRENT LIMIT TO 6 CM WHILE PROVIDING HIGH SPATIAL RESOLUTION. ACHIEVING THIS AMBITION REQUIRES FUNDAMENTAL IMPROVEMENTS ACROSS THE ENTIRE IMAGING CHAIN, FROM OPTICAL EXCITATION TO ULTRASONIC DETECTION AND IMAGE RECONSTRUCTION. WE PROPOSE THE FOLLOWING ADVANCEMENTS: (1) OPTIMIZING SNR BY SCANNING LASER PULSES WITH A HIGHER REPETITION RATE TO SATISFY BOTH ANSI SAFETY LIMITS AND INCORPORATING ULTRASONIC EXCITATION FOR ACCURATE ACOUSTIC SPEED-OF- SOUND IMAGING AND DE-ABERRATION, (2) ENHANCING ULTRASONIC DETECTION BY MAXIMIZING THE DETECTION SOLID ANGLE AND PACKING DENSITY (I.E., FILL FACTOR) WHILE PROVIDING SPATIAL NYQUIST SAMPLING WITH CODED MASKING, (3) REFINING JOINT RECONSTRUCTION AUGMENTED BY ULTRASONIC EXCITATION TO DE-ABERRATE ACOUSTIC BLURRING AND TAILORING MOTION CORRECTION TO MITIGATE MOTION ARTIFACTS OVER EXTENDED ACQUISITION TIMES, AND (4) PERFORMING IN VIVO IMAGING OF HUMAN BREASTS TO VALIDATE THE PROPOSED TECHNOLOGY USING CONTRAST-ENHANCED MRI AS THE GOLD STANDARD OWING TO ITS SHARED ABILITY WITH PAT TO IMAGE BLOOD VESSELS. THE TEAM HAS ACHIEVED MULTIPLE MILESTONES IN PAT, INCLUDING THE FIRST IN VIVO FUNCTIONAL PAT, THE FIRST 3D PHO- TOACOUSTIC MICROSCOPY WITH CELLULAR RESOLUTION, AND THE MOST WIDELY ADOPTED PAT RECONSTRUCTION METHOD. THESE FOUNDATIONAL CONTRIBUTIONS HAVE ESTABLISHED PAT AS THE LEADING HIGH-RESOLUTION OPTICAL IMAGING TECHNIQUE IN TERMS OF DEEP-TISSUE PENETRATION. DESPITE ITS SUCCESS, FURTHER TECHNICAL BREAKTHROUGHS ARE REQUIRED TO ADDRESS THE CHALLENGES OF PROVIDING EVEN GREATER PENETRATION. THIS PROPOSAL INTRODUCES A SYNERGISTIC APPROACH BY OPTIMIZING LASER DELIVERY, ULTRASONIC DETECTION, ACOUSTIC DE- ABERRATION, AND ADVANCED RECONSTRUCTION ALGORITHMS TO ACHIEVE A QUANTUM LEAP IN PAT. THE PROPOSED INNOVATIONS WILL SIGNIFICANTLY ENHANCE PAT’S DIAGNOSTIC POTENTIAL IN BIOMEDICINE, PARTICULARLY IN BREAST CANCER DETECTION, WHERE DEEP-TISSUE VISUALIZATION IS CRITICAL FOR EARLY DETECTION AND TREATMENT MONITORING. THE IMPACT OF THIS RESEARCH EXTENDS TO A BROAD RANGE OF BIOMEDICAL APPLICATIONS. IN SUMMARY, BY SYSTEMATICALLY IMPROVING PAT FROM EXCITATION TO DETECTION AND RECONSTRUCTION, THIS WORK WILL ES- TABLISH THE NEXT-GENERATION PAT, CAPABLE OF TRANSFORMING CLINICAL IMAGING. THE PROPOSED RESEARCH ALIGNS WITH THE LONG-TERM GOAL OF DEVELOPING PAT INTO A WIDELY ACCESSIBLE, NON-INVASIVE IMAGING TOOL THAT PROVIDES GREATER IMAGING DEPTHS WITH HIGH RESOLUTION.
Funding Goals
<P><SPAN STYLE="BACKGROUND-COLOR:WHITE;">THE OFFICE OF STRATEGIC COORDINATION (</SPAN><A HREF="HTTPS://COMMONFUND.NIH.GOV/"><SPAN STYLE="BACKGROUND-COLOR:WHITE;">COMMON FUND</SPAN></A><SPAN STYLE="BACKGROUND-COLOR:WHITE;">)</SPAN><SPAN STYLE="BACKGROUND-COLOR:#F9F9F9;"> SUPPORTS RESEARCH AND OTHER PROJECTS THAT WILL ACCELERATE FUNDAMENTAL BIOMEDICAL DISCOVERY AND TRANSLATION OF THAT KNOWLEDGE INTO EFFECTIVE PREVENTION STRATEGIES AND NEW TREATMENTS.</SPAN></P>
Place of Performance
Pasadena, California 911250001 United States
Geographic Scope
Single Zip Code
California Institute Of Technology was awarded Next-Gen Photoacoustic CT for Deep Tissue Imaging Cooperative Agreement UG3DA065155 worth $3,179,146 from the National Institute of Allergy and Infectious Diseases in September 2025 with work to be completed primarily in Pasadena California United States. The grant has a duration of 2 years and was awarded through assistance program 93.310 Trans-NIH Research Support. The Cooperative Agreement was awarded through grant opportunity In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed.

Status
(Ongoing)

Last Modified 9/5/25

Period of Performance
9/1/25
Start Date
8/31/27
End Date
1.0% Complete

Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UG3DA065155

Additional Detail

Award ID FAIN
UG3DA065155
SAI Number
UG3DA065155-3028135524
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
U2JMKHNS5TG4
Awardee CAGE
80707
Performance District
CA-28
Senators
Dianne Feinstein
Alejandro Padilla
Modified: 9/5/25